APRIL 21-23, 2020

BOSTON, MA USA

Arrowhead Publishers Announces the Preliminary Speaker Faculty for 6th Annual Translational Microbiome Conference

November 7, 2019 – Minneapolis, MN – Arrowhead Publishers has announced the preliminary speaking faculty for the 6th Annual Translational Microbiome Conference. This conference, taking place April 21-23, 2020 in Boston, MA, will once again bring together the top researchers, leaders, companies and institutions in the field of microbiome science to share novel research, discuss issues relating to the commercialization of microbiome-based products and share new findings relating to the microbiome that are relevant for healthcare providers

This year’s conference will continue to focus and build on the challenges and hurdles that companies working in the microbiome industry will have to recognize and navigate in order to successfully commercialize their products.

Key subject covered include:

• Research standards
• Manufacturing challenges
• Funding issues and challenges
• Therapeutic interventions undergoing clinical trials
• Novel microbiome science
• Gut-brain axis
• Microbiome sampling and diagnostics

For more information on the conference, visit www.microbiomeconference.com.

Speakers Include:
• Rachel Clemens, Ph.D., Commercial Innovation Manager, Life Science Lead, ISS US National Lab, Center for Advancement in Science in Space
• Lynne Elmore, Ph.D., Director, Translational Cancer Research Program, American Cancer Society
• Garth Ehrlich, Ph.D., Professor of Microbiology & Immunology, Professor of Otolaryngology - Head and Neck Surgery, Drexel University College of Medicine
• Wendy Garrett, Ph.D., Professor of Immunology and Infectious Diseases, Department of Immunology and Infectious Diseases, Department of Genetics and Complex Diseases, Department of Medicine, Harvard Medical School
• Momo Vuyisch, Ph.D., Chief Scientific Officer, Viome
• Shahram Lavasani, Ph.D., Founder, CEO/CSO, Immune Biotech
• Scott Jackson, Ph.D., Group Leader, Complex Microbial Systems, NIST
• Nancy Caralla, Founding President, Executive Director, C Diff Foundation
• Rachel Teitelbaum, Ph.D., Chief Executive Officer, Hervana
• Sonia Timberlake, Ph.D., Vice President of Research, Finch Therapeutics
• Dae-Wook Kang, Ph.D., Assistant Professor, Department of Civil & Environmental Engineering, University of Toledo
• Sameer Sonkusale, Ph.D., Professor of Electrical and Computer Engineering, Professor of Biomedical Engineering (adjunct), Director/Principal Investigator, Nano Lab, Tufts University
• Amy Feehan, Ph.D., Research Scientist, Ochsner Health System
• Ze'ev Ronai, Ph.D., Professor, Sanford Burnham Prebys Medical Discovery Institute
• Sangeeta Khare, Ph.D., Research Microbiologist, National Center for Toxicological Research, US Food and Drug Administration
• Lionel Breton, Ph.D., DSc, Scientific Director, L'Oreal Advanced Research, L'Oreal
• Anandh Babu Pon Velayutham, Ph.D., Associate Professor, Nutrition and Integrative Physiology, University of Utah
• Sara Ferrando Martinez, Ph.D., Research Scientist, AstraZeneca
• Julius Goepp, MD, Chief Executive Officer, Scaled Microbiomics
• Stewart Campbell, Ph.D., Vice President, Early Stage Development, Axial Biotherapeutics
• Gregg Silverman, MD, Professor of Medicine and Pathology, New York University School of Medicine
• Henri Haiser, Ph.D., Associate Scientific Director, GI Drug Discovery, Microbiome Sciences, Takeda
• Steve Schnittger, VP Global Microbiology R&D, Estee Lauder
• Mahmoud Ghannoum, Ph.D., EMBA, Professor, Department of Dermatology, Case Western Reserve University and University Hospitals Cleveland Medical Center

For the full list of speakers, CLICK HERE.


For more information, please contact:
John Waslif: Conference Director
Arrowhead Publishers
866-945-0263 ext 700
This email address is being protected from spambots. You need JavaScript enabled to view it.

Continuing Medical Education Credits Now Available for this Event

Joint-Providership Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Office of Continuing Medical Education of the University of Virginia School of Medicine and Arrowhead Publishers. The Office of Continuing Medical Education of the University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

The University of Virginia School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity. (The number of credits offered for this event is subject to change dependent upon future additions/revisions to the agenda.)

The University of Virginia School of Medicine, as accredited provider, awards 4.25 hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)TM ) to a participant who successfully completes this educational activity. The University of Virginia School of Medicine maintains a record of participation for six (6) years.